BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11955478)

  • 1. Identification and functional characterization of the novel isoforms of bovine norepinephrine transporter produced by alternative splicing.
    Kitayama S; Kumagai K; Morita K; Dohi T
    Brain Res; 2002 May; 934(2):152-6. PubMed ID: 11955478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of the splicing variants of human norepinephrine transporter.
    Kitayama S; Morita K; Dohi T
    Neurosci Lett; 2001 Oct; 312(2):108-12. PubMed ID: 11595346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional importance of the C-terminus of the human norepinephrine transporter.
    Distelmaier F; Wiedemann P; Brüss M; Bönisch H
    J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6.
    Sogawa C; Mitsuhata C; Kumagai-Morioka K; Sogawa N; Ohyama K; Morita K; Kozai K; Dohi T; Kitayama S
    PLoS One; 2010 Aug; 5(8):e11945. PubMed ID: 20700532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing.
    Kitayama S; Ikeda T; Mitsuhata C; Sato T; Morita K; Dohi T
    J Biol Chem; 1999 Apr; 274(16):10731-6. PubMed ID: 10196144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal region regulates the functional expression of human noradrenaline transporter splice variants.
    Sogawa C; Kumagai K; Sogawa N; Morita K; Dohi T; Kitayama S
    Biochem J; 2007 Jan; 401(1):185-95. PubMed ID: 16965261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
    Paczkowski FA; Bönisch H; Bryan-Lluka LJ
    Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine transporter splice variants and their interaction with substrates and blockers.
    Kitayama S; Dohi T
    Eur J Pharmacol; 2003 Oct; 479(1-3):65-70. PubMed ID: 14612138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats.
    Shang Y; Dluzen DE
    Neurosci Lett; 2002 Aug; 328(2):81-4. PubMed ID: 12133560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the murine splice variant Mobp155: developmental CNS expression pattern and subcellular localization of epitope-tagged protein.
    Montague P; McCallion AS; Barrie JE; Edgar JM; McLaughlin M; Davies RW; Griffiths IR
    Glia; 2005 Apr; 50(1):80-5. PubMed ID: 15625715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells.
    Obara G; Toyohira Y; Inagaki H; Takahashi K; Horishita T; Kawasaki T; Ueno S; Tsutsui M; Sata T; Yanagihara N
    J Pharmacol Sci; 2013; 121(2):138-47. PubMed ID: 23370666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: implications for CNS glutamate homeostasis.
    Sullivan R; Rauen T; Fischer F; Wiessner M; Grewer C; Bicho A; Pow DV
    Glia; 2004 Jan; 45(2):155-69. PubMed ID: 14730709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
    Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
    J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
    Zhu MY; Shamburger S; Li J; Ordway GA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
    Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
    Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons.
    Pörzgen P; Bönisch H; Hammermann R; Brüss M
    Biochim Biophys Acta; 1998 Jul; 1398(3):365-70. PubMed ID: 9655936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the norepinephrine transporter in the rat CNS.
    Sanders JD; Happe HK; Bylund DB; Murrin LC
    Neuroscience; 2005; 130(1):107-17. PubMed ID: 15561429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenergic terminals are the primary source of α
    Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
    Reith ME; Wang LC; Dutta AK
    J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1 (DAX-1) by alternative splicing.
    Hossain A; Li C; Saunders GF
    Mol Endocrinol; 2004 Jun; 18(6):1428-37. PubMed ID: 15044589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.